discoveric bio group
3 contactsdiscovericbio.com
Discoveric Bio Group is a private Swiss biotechnology firm in Pfaffikon, Zurich. It develops multispecific natural antibody therapeutics aimed at Alzheimer's Disease and antimicrobial resistance. The group consists of three independent entities, each led by experienced pharma and biotech professionals.
| Investor | Type | Based in | Focus | AUM | Contacts |
|---|---|---|---|---|---|
| New York Life Investment Management | Asset Manager | New York | Multifamily · Industrial · Co-investment | $740B | 5 |
| Brookfield Asset Management | Asset Manager | Toronto, Canada | Multifamily · Industrial · Opportunistic · Joint venture | $690B | 12 |
| KKR | Asset Manager | New York | Multifamily · Industrial · Core · Co-investment | $553B | 11 |
| Ares Management | Asset Manager | Los Angeles | Multifamily · Industrial · Core | $546B | 16 |
| Neuberger Berman - Fund of Funds and Secondary | Fund of Funds | New York | Multifamily · Industrial · Co-investment | $538B | 17 |
| Temasek | Sovereign Wealth Fund | Singapore | Industrial · Office · Joint venture | $311B | 5 |
Filter the full list by property type, strategy, market and deal format.
